Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

CrescNet - Growth Monitoring Network (CrescNet)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03072537
Recruitment Status : Recruiting
First Posted : March 7, 2017
Last Update Posted : July 27, 2020
Sponsor:
Information provided by (Responsible Party):
Antje Koerner, Prof. Dr. med., University of Leipzig

Brief Summary:
CrescNet is a network of primary care physicians and pediatricians (n=219) and endocrinological treatment centers (n=33), established in Leipzig in 1998, whose aim is to improve the early detection of growth disorders. Secondary to this clinical aim, epidemiological analyses, for example on secular trends of growth data of children, are performed.

Condition or disease
Obesity Child Development Growth Disorders

Detailed Description:

Pediatricians participating in CrescNet provide pseudononymized data on patients' height, weight, and head circumferences to the CrescNet registry. Growth data are evaluated by automatized filter algorithms and by a pediatric endocrinologist. CrescNet does not have access to patients or personal patient data. Each participating pediatrician receives a quarterly screening report with recommendations for the work-up of children with abnormal growth or abnormal development of weight or body mass index.

The data registry is used for scientific purposes.The collection of data from healthy children allows the generation of evidence based statements about prevalence rates of growth disorders and also about the rates in disorders of weight development. For this, data are provided completely anonymized without allowing conclusions on personal patient data.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 1000000 participants
Observational Model: Other
Time Perspective: Prospective
Target Follow-Up Duration: 18 Years
Official Title: CrescNet - Computer-guided, Population-based Surveillance System for Growth Disorders
Actual Study Start Date : January 1, 1998
Estimated Primary Completion Date : January 1, 2028
Estimated Study Completion Date : January 1, 2028

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Growth Disorders




Primary Outcome Measures :
  1. growth disorders [ Time Frame: 18 years ]
    Early detection of growth disorders in childhood and adolescent development. For this, not only absolute data but also growth velocity data are evaluated.

  2. obesity [ Time Frame: 18 years ]
    detection of critical age periods for the development of obesity. For this, not only absolute data but also growth velocity data are evaluated.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
479, 576 boys with 2,570, 041 visits und 453,510 girls with 2,427,350 visits from screening and/or consulting visits at 1 of the 435 participating German pediatricians.
Criteria

Inclusion Criteria: Population based sample with inclusion of any patient seen by primary care or institutional physician/pediatrician, regardless of the objective for the visit (well child visits, acute visits or special requests)

Exclusion Criteria: none


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03072537


Contacts
Layout table for location contacts
Contact: Roland W Pfäffle, MD roland.pfaeffle@medizin.uni-leipzig.de
Contact: Ruth Gausche gausche@crescnet.org

Locations
Layout table for location information
Germany
CrescNet - University of Leipzig Recruiting
Leipzig, Saxony, Germany, 04103
Contact: Roland W Pfäffle, MD       roland.pfaeffle@medizin.uni-leipzig.de   
Contact: Ruth Gausche       gausche@crescnet.org   
Sponsors and Collaborators
University of Leipzig
Investigators
Layout table for investigator information
Principal Investigator: Roland W Pfäffle, MD University of Leipzig
Additional Information:
Publications of Results:

Other Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Antje Koerner, Prof. Dr. med., Prof. Dr. med. Antje Körner, University of Leipzig
ClinicalTrials.gov Identifier: NCT03072537    
Other Study ID Numbers: CrescNet
First Posted: March 7, 2017    Key Record Dates
Last Update Posted: July 27, 2020
Last Verified: July 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Antje Koerner, Prof. Dr. med., University of Leipzig:
growth
BMI
obesity
childhood
adolescence
development
Additional relevant MeSH terms:
Layout table for MeSH terms
Growth Disorders
Pathologic Processes